These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7982239)

  • 1. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.
    Vangsted A; Drivsholm L; Andersen E; Bock E
    Cancer Detect Prev; 1994; 18(4):291-8. PubMed ID: 7982239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1.
    Vangsted A; Drivsholm L; Andersen E; Pallesen T; Zeuthen J; Wallin H
    Cancer Detect Prev; 1994; 18(3):221-9. PubMed ID: 8076384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serum.
    Vangsted AJ; Clausen H; Kjeldsen TB; White T; Sweeney B; Hakomori S; Drivsholm L; Zeuthen J
    Cancer Res; 1991 Jun; 51(11):2879-84. PubMed ID: 1851663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes.
    Waibel R; Mannhart M; O'Hara CJ; Brocklehurst C; Zangemeister-Wittke U; Schenker T; Lehmann HP; Weber E; Stahel RA
    Cancer Res; 1993 Jun; 53(12):2840-5. PubMed ID: 7684948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J; Li R; Li A
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):216-8. PubMed ID: 11778234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pseudouridine as a biochemical marker in small cell lung cancer.
    Tamura S; Fujioka H; Nakano T; Hada T; Higashino K
    Cancer Res; 1987 Nov; 47(22):6138-41. PubMed ID: 2822241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tumor-associated neural cell adhesion molecule in human serum.
    Takamatsu K; Auerbach B; Gerardy-Schahn R; Eckhardt M; Jaques G; Madry N
    Cancer Res; 1994 May; 54(10):2598-603. PubMed ID: 7513253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212.
    Moolenaar CE; Muller EJ; Schol DJ; Figdor CG; Bock E; Bitter-Suermann D; Michalides RJ
    Cancer Res; 1990 Feb; 50(4):1102-6. PubMed ID: 2153450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
    Drivsholm L; Vangsted A; Pallesen T; Hansen M; Dombernowsky P; Hirsch F; Hansen HH
    Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3021-4. PubMed ID: 9329591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
    Karapanagiotou EM; Pelekanou E; Charpidou A; Tsaganos T; Anagnostou V; Plachouras D; Giamarellos-Bourboulis EJ; Syrigos KN
    Anticancer Res; 2008; 28(2B):1411-5. PubMed ID: 18505088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-gastrin-releasing peptide(31-98) is a specific tumor marker in patients with small cell lung carcinoma.
    Miyake Y; Kodama T; Yamaguchi K
    Cancer Res; 1994 Apr; 54(8):2136-40. PubMed ID: 8174119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum endostatin levels in patients with lung carcinoma.
    Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
    Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
    Oshita F; Sekiyama A; Suzuki R; Ikehara M; Yamada K; Saito H; Noda K; Miyagi Y
    Oncol Rep; 2003; 10(1):105-8. PubMed ID: 12469153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S; Ma Y; Yang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.